ConductScience.org, home

Paper39089

Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.

Gruetter CA and 5 others. J Cyclic Nucleotide Res, 1979. Cited by 549 papers, by iCite.

Cite this record

ConductScience Library. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. Papers, record 39089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39089

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.
PubMed
Journal
J Cyclic Nucleotide Res
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
549
iCite
Relative citation ratio, by iCite
16.3
iCite
Revised in PubMed
2022-03-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gruetter CAC A
2Barry BKB K
3McNamara DBD B
4Gruetter DYD Y
5Kadowitz PJP J
6Ignarro LL

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerricyanidesMajor topic
Guanylate CyclaseMajor topic
MethylnitronitrosoguanidineMajor topic
Muscle, Smooth, VascularMajor topic
Nitric OxideMajor topic
NitroprussideMajor topic
Animals
Arteries
Cattle
Coronary Vessels
Enzyme Activation
Hemeproteins
Muscle Relaxation

Source PubMed

Download CSV of topics

Cited by118

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 549 citations.

PMIDTitleJournalYearIn PapersSource
41188152Gasotransmitter signaling in the brain: New frontiers for therapeutics.Neurotherapeutics2025https://conductscience.org/library/papers/41188152PubMed
40769850Hydrogen sulfide/polysulfides signaling and neuronal diseases.Neurotherapeutics2025https://conductscience.org/library/papers/40769850PubMed
40760267Efficacy of Treating Nifedipine-Induced Shock with Hydroxocobalamin in a Swine Model.J Med Toxicol2025https://conductscience.org/library/papers/40760267PubMed
40560510Evidence-Based Supplementation Strategies for Wrestlers: A Systematic Review.Curr Nutr Rep2025https://conductscience.org/library/papers/40560510PubMed
37189703Nitric Oxide in Cardiac Surgery: A Review Article.Biomedicines2023https://conductscience.org/library/papers/37189703PubMed
36984866Cross-Regulation of the Cellular Redox System, Oxygen, and Sphingolipid Signalling.Metabolites2023https://conductscience.org/library/papers/36984866PubMed
36432022Biological Assessment of the NO-Dependent Endothelial Function.Molecules2022https://conductscience.org/library/papers/36432022PubMed
35754072Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases.Intensive Care Med Exp2022https://conductscience.org/library/papers/35754072PubMed
35745248An Exploration of How Solar Radiation Affects the Seasonal Variation of Human Mortality Rates and the Seasonal Variation in Some Other Common Disorders.Nutrients2022https://conductscience.org/library/papers/35745248PubMed
35616143Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).Mol Med Rep2022https://conductscience.org/library/papers/35616143PubMed
35076566Nitric Oxide: The Missing Factor in COVID-19 Severity?Med Sci (Basel)2021https://conductscience.org/library/papers/35076566PubMed
34365128Gemfibrozil derivatives as activators of soluble guanylyl cyclase - A structure-activity study.Eur J Med Chem2021https://conductscience.org/library/papers/34365128PubMed
32370259Senescence and Cancer: Role of Nitric Oxide (NO) in SASP.Cancers (Basel)2020https://conductscience.org/library/papers/32370259PubMed
31187898Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.Compr Physiol2019https://conductscience.org/library/papers/31187898PubMed
30587924Cytoprotective effects of molsidomine against methotrexate-induced hepatotoxicity: an experimental rat study.Drug Des Devel Ther2019https://conductscience.org/library/papers/30587924PubMed
30556130Nitric oxide is not just blowing in the wind.Br J Pharmacol2019https://conductscience.org/library/papers/30556130PubMed
30308037Effects of the nitric oxide releasing biomimetic nanomatrix gel on pulp-dentin regeneration: Pilot study.PLoS One2018https://conductscience.org/library/papers/30308037PubMed
30063800Nitric oxide and its role as a non-adrenergic, non-cholinergic inhibitory neurotransmitter in the gastrointestinal tract.Br J Pharmacol2019https://conductscience.org/library/papers/30063800PubMed
29744429Nanomaterials for treating cardiovascular diseases: A review.Bioact Mater2017https://conductscience.org/library/papers/29744429PubMed
29552696Mechanism of vasorelaxation induced by 3'-hydroxy-5,6,7,4'-tetramethoxyflavone in the rats aortic ring assay.Naunyn Schmiedebergs Arch Pharmacol2018https://conductscience.org/library/papers/29552696PubMed

See all 118 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39089

GET https://conductscience.org/api/papers/v1/39089/cited_by?page=2